Method for producing immune cells and method for inducing immune effector cells

A technology of immune cells and immune function, applied in biochemical equipment and methods, microorganisms, tissue culture, etc., can solve problems such as virus contamination and infection

Active Publication Date: 2010-12-29
VECTORITE BIOMEDICA +1
View PDF0 Cites 9 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the use of virus or virus-infected cells as an antigen source has the potential risk of virus contamination and infection; and the use of full-length herpes virus genes or proteins as an antigen source can induce immune suppression or immune resistance. The issue of immune tolerance

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for producing immune cells and method for inducing immune effector cells
  • Method for producing immune cells and method for inducing immune effector cells
  • Method for producing immune cells and method for inducing immune effector cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0037] Since the present invention discloses a method for producing immune cells and a method for inducing the production of immune cells, the immunological principles, cell culture, cell staining and detection and other related technologies used therein are those with ordinary knowledge in the relevant technical field It can be understood, so the description below will not make a complete description. At the same time, the diagrams compared in the following text are schematic representations related to the features of the present invention, and are not and need not be completely drawn according to the actual situation, so they will be described first.

[0038]The first embodiment of the present invention provides a method for producing immune cells, which includes the following steps: mixing and culturing immune cells and an immunogen composition, and the immunogen composition used contains at least two Peptides of virus type IV. The immune cells can be antigen presenting ce...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a method for producing immune cells and a method for inducing immune effector cells. The method for producing the immune cells comprises the following step: carrying out mixed culture on the immune cells and an immunogen composition, wherein, the immunogen composition comprises at least two types of peptide derived from human herpesvirus-4 or a peptide library and can alsocomprise an immuno-adjuvant. In addition, the method for inducing the immune effector cells: mixing antigen presenting cells with the immunogen composition to obtain a culture; and co-culturing the obtained culture with lymphocyte in an appropriate culture medium to obtain activated immune effector cells, wherein, the culture medium can also comprise the immuno-adjuvant, and the obtained activated immune effector cell can be used for producing anti-EBA (Epstein-Barrvirus) immune reaction.

Description

technical field [0001] The present invention relates to a method for generating immune cells, especially for generating immune cells against herpes virus. Background technique [0002] In 1964, Achong and Barr et al. first isolated and discovered Epstein-Barr Virus (Epstein-Barr Virus, EBV) from the cells of Burch's lymphoma patients. The Chinese name is "Human herpesvirus type IV" (Human herpesvirus -4, HHV-4), a linear double-stranded DNA virus belonging to the family Herpesviridae. [0003] Like most herpes viruses, EBV has two life histories: Lytic phase and Latent phase. Among them, the cell lysis period mostly occurs in epithelial cells, because the virus will replicate in large numbers in the cell, and finally cause the cell to rupture and release a large amount of virus. The incubation period mostly occurs in B lymphocytes. EBV is embedded in the gene body of B lymphocytes to avoid the attack of immune cells. At the same time, it may also cause abnormal proliferati...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C12N5/08
Inventor 梁莹
Owner VECTORITE BIOMEDICA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap